SecSonar.com

West Pharmaceutical Services, Inc. (WST)

West Pharmaceutical Services, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

West Pharmaceutical Services, Inc. (WST) is a Medical - Instruments & Supplies company based in US with a market capitalization of $22.6B. Revenue grew 6.3% year-over-year and the company generated $468.9M in free cash flow. This page tracks WST's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 10.6K employees · IPO Mar 17, 1980

Valuation

Valuation & price

$302.89 · as of May 17, 2026 · -17.3% vs 52w high

44.6

P/E ratio

Latest-FY diluted EPS

7.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$366$288$210Jul 25Dec 25Jul 26Jul 7, 25$221.48Jul 9, 25$226.18Jul 11, 25$227.18Jul 15, 25$221.05Jul 17, 25$221.59Jul 21, 25$210.08Jul 23, 25$227.31Jul 25, 25$263.51Jul 29, 25$252.94Jul 31, 25$239.26Aug 4, 25$238.39Aug 6, 25$237.28Aug 11, 25$240.33Aug 13, 25$246.22Aug 15, 25$246.20Aug 19, 25$246.99Aug 21, 25$242.63Aug 25, 25$247.21Aug 27, 25$245.97Aug 29, 25$246.95Sep 3, 25$248.95Sep 5, 25$250.73Sep 9, 25$252.04Sep 11, 25$263.74Sep 16, 25$258.35Sep 18, 25$254.98Sep 22, 25$252.22Sep 24, 25$259.94Sep 26, 25$261.52Sep 30, 25$262.33Oct 2, 25$273.16Oct 6, 25$268.07Oct 8, 25$267.93Oct 10, 25$261.77Oct 14, 25$261.17Oct 16, 25$267.19Oct 21, 25$279.39Oct 23, 25$307.25Oct 27, 25$287.22Oct 29, 25$284.86Oct 31, 25$282.07Nov 4, 25$286.94Nov 6, 25$275.34Nov 10, 25$275.47Nov 12, 25$273.85Nov 14, 25$261.36Nov 18, 25$260.14Nov 20, 25$257.77Nov 25, 25$280.84Nov 28, 25$277.25Dec 2, 25$273.03Dec 4, 25$281.77Dec 8, 25$269.08Dec 10, 25$266.96Dec 12, 25$267.56Dec 16, 25$266.44Dec 18, 25$268.66Dec 22, 25$274.89Dec 24, 25$276.66Dec 29, 25$275.60Jan 2, 26$276.40Jan 6, 26$280.66Jan 8, 26$275.23Jan 12, 26$272.91Jan 14, 26$274.98Jan 16, 26$259.79Jan 21, 26$255.16Jan 23, 26$236.66Jan 27, 26$240.53Jan 29, 26$232.65Feb 2, 26$237.50Feb 4, 26$237.05Feb 9, 26$248.93Feb 11, 26$246.16Feb 13, 26$250.49Feb 18, 26$248.26Feb 20, 26$241.12Feb 24, 26$245.38Feb 26, 26$249.02Mar 2, 26$251.25Mar 4, 26$248.84Mar 6, 26$245.86Mar 10, 26$233.83Mar 12, 26$231.09Mar 17, 26$239.42Mar 19, 26$240.33Mar 23, 26$241.40Mar 25, 26$247.02Mar 27, 26$243.35Mar 31, 26$250.64Apr 2, 26$254.80Apr 7, 26$259.35Apr 9, 26$258.54Apr 13, 26$259.96Apr 15, 26$266.50Apr 17, 26$273.73Apr 22, 26$274.41Apr 24, 26$306.16Apr 28, 26$292.13Apr 30, 26$297.59May 4, 26$300.18May 6, 26$312.55May 8, 26$325.92May 12, 26$312.07May 14, 26$300.19May 18, 26$304.41May 20, 26$305.50May 22, 26$316.42May 28, 26$321.80Jun 1, 26$316.30Jun 3, 26$316.31Jun 5, 26$314.50Jun 9, 26$334.66Jun 11, 26$330.34Jun 15, 26$331.43Jun 17, 26$323.59Jun 22, 26$329.71Jun 24, 26$340.41Jun 26, 26$350.85Jul 2, 26$366.08
$210.0852-week range$366.08
Loading valuation history…

Fundamentals

Key fundamentals

$22.6B

Market cap

6.3%

Revenue growth (YoY)

35.9%

Gross margin

$468.9M

Free cash flow (USD)

-$374.6M

Net debt

Net cash position

-1.0%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.5BFY 2017$1.6BFY 2018$1.7BFY 2019$1.8BFY 2020$2.1BFY 2021$2.8BFY 2022$2.9BFY 2023$3.0BFY 2024$2.9BFY 2025$3.1B
$1.5B$3.1B

Free cash flow by year

2016 → 2025

FY 2016$49.2MFY 2017$132.5MFY 2018$183.9MFY 2019$240.8MFY 2020$298.1MFY 2021$330.6MFY 2022$439.4MFY 2023$414.5MFY 2024$276.4MFY 2025$468.9M
$49.2M$468.9M

Gross margin by year

2021 → 2025

FY 202141.5%FY 202239.5%FY 202338.4%FY 202434.6%FY 202535.9%
41.5%35.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 23, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCEO AppointmentJun 1, 2026Filing
  • 8-K eventCybersecurity Incident UpdateMay 20, 2026Filing
  • 8-K eventCybersecurity IncidentMay 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 5, 2026Filing
  • Insider sellInsider Sell $269KWinters Chad · VP, Chief Accounting Officer · $269.4KApr 29, 2026Filing
  • Insider sellInsider Sell $860KFavorite Annette F · Sr. VP & Chief HR Officer · $859.8KApr 29, 2026Filing
  • 8-K eventEarnings ReleaseApr 23, 2026Filing
  • Quarterly report10-Q FiledApr 23, 2026Filing

Questions

Frequently asked questions

What is West Pharmaceutical Services, Inc.'s market cap?

West Pharmaceutical Services, Inc. (WST) has a market capitalization of $22.6B.

What is WST's P/E ratio?

WST trades at a price-to-earnings ratio of 44.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is WST's price-to-book (P/B) ratio?

WST trades at 7.11 times book value per share.

Are insiders buying WST stock?

SEC Form 4 filings show no open-market insider buys at West Pharmaceutical Services, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Instruments & Supplies

MDLN

Medline Inc.

$31.2B

ALC

Alcon Inc.

$32.5B

COO

The Cooper Companies, Inc.

$12B

BAX

Baxter International Inc.

$9.8B

ATR

AptarGroup, Inc.

$7.4B

RGEN

Repligen Corporation

$7.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.